Historically, DCIS has not been routinely evaluated for ER status, but research studies have found that the proportion of ER positivity at 62–76% (22, 23, 25, 54) is similar to that observed in IBC (55, 56). The gene discussed is ESR1; the disease is inflammatory breast carcinoma.